Renal Cell Carcinoma Clinical Trial Pipeline Market - Global Outlook and Forecast 2021-2027

March 2021 | 92 pages | ID: R1F38B4DF69FEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Renal Cell Carcinoma Clinical Trial Pipeline in Global, including the following market information:

Global Renal Cell Carcinoma Clinical Trial Pipeline Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Renal Cell Carcinoma Clinical Trial Pipeline market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Renal Cell Carcinoma Clinical Trial Pipeline companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Renal Cell Carcinoma Clinical Trial Pipeline Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Renal Cell Carcinoma Clinical Trial Pipeline Market Segment Percentages, By Type, 2020 (%)

• Targeted Therapy
• Immunotherapy

China Renal Cell Carcinoma Clinical Trial Pipeline Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Renal Cell Carcinoma Clinical Trial Pipeline Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Research Institute
• Commercial
• Other

Global Renal Cell Carcinoma Clinical Trial Pipeline Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Renal Cell Carcinoma Clinical Trial Pipeline Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Renal Cell Carcinoma Clinical Trial Pipeline Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Renal Cell Carcinoma Clinical Trial Pipeline Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Amgen
• Argos Therapeutics
• AstraZeneca
• Aveo Pharmaceuticals
• Bayer
• Exelixis
• Incyte
• Merck KGaA
• Roche
• Novartis
• Pfizer
• Prometheus Labs

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Renal Cell Carcinoma Clinical Trial Pipeline Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Renal Cell Carcinoma Clinical Trial Pipeline Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RENAL CELL CARCINOMA CLINICAL TRIAL PIPELINE OVERALL MARKET SIZE

2.1 Global Renal Cell Carcinoma Clinical Trial Pipeline Market Size: 2021 VS 2027
2.2 Global Renal Cell Carcinoma Clinical Trial Pipeline Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Renal Cell Carcinoma Clinical Trial Pipeline Players in Global Market
3.2 Top Global Renal Cell Carcinoma Clinical Trial Pipeline Companies Ranked by Revenue
3.3 Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue by Companies
3.4 Top 3 and Top 5 Renal Cell Carcinoma Clinical Trial Pipeline Companies in Global Market, by Revenue in 2020
3.5 Global Companies Renal Cell Carcinoma Clinical Trial Pipeline Product Type
3.6 Tier 1, Tier 2 and Tier 3 Renal Cell Carcinoma Clinical Trial Pipeline Players in Global Market
  3.6.1 List of Global Tier 1 Renal Cell Carcinoma Clinical Trial Pipeline Companies
  3.6.2 List of Global Tier 2 and Tier 3 Renal Cell Carcinoma Clinical Trial Pipeline Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Renal Cell Carcinoma Clinical Trial Pipeline Market Size Markets, 2021 & 2027
  4.1.2 Targeted Therapy
  4.1.3 Immunotherapy
4.2 By Type - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue & Forecasts
  4.2.1 By Type - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue, 2016-2021
  4.2.2 By Type - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue, 2022-2027
  4.2.3 By Type - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Research Institute
  5.1.4 Commercial
  5.1.5 Other
5.2 By Application - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue & Forecasts
  5.2.1 By Application - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue, 2016-2021
  5.2.2 By Application - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue, 2022-2027
  5.2.3 By Application - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2021 & 2027
6.2 By Region - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue & Forecasts
  6.2.1 By Region - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue, 2016-2021
  6.2.2 By Region - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue, 2022-2027
  6.2.3 By Region - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Renal Cell Carcinoma Clinical Trial Pipeline Revenue, 2016-2027
  6.3.2 US Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.3.3 Canada Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.3.4 Mexico Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Renal Cell Carcinoma Clinical Trial Pipeline Revenue, 2016-2027
  6.4.2 Germany Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.4.3 France Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.4.4 U.K. Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.4.5 Italy Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.4.6 Russia Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.4.7 Nordic Countries Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.4.8 Benelux Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Renal Cell Carcinoma Clinical Trial Pipeline Revenue, 2016-2027
  6.5.2 China Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.5.3 Japan Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.5.4 South Korea Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.5.5 Southeast Asia Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.5.6 India Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Renal Cell Carcinoma Clinical Trial Pipeline Revenue, 2016-2027
  6.6.2 Brazil Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.6.3 Argentina Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Renal Cell Carcinoma Clinical Trial Pipeline Revenue, 2016-2027
  6.7.2 Turkey Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.7.3 Israel Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.7.4 Saudi Arabia Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027
  6.7.5 UAE Renal Cell Carcinoma Clinical Trial Pipeline Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Amgen
  7.1.1 Amgen Corporate Summary
  7.1.2 Amgen Business Overview
  7.1.3 Amgen Renal Cell Carcinoma Clinical Trial Pipeline Major Product Offerings
  7.1.4 Amgen Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (2016-2021)
  7.1.5 Amgen Key News
7.2 Argos Therapeutics
  7.2.1 Argos Therapeutics Corporate Summary
  7.2.2 Argos Therapeutics Business Overview
  7.2.3 Argos Therapeutics Renal Cell Carcinoma Clinical Trial Pipeline Major Product Offerings
  7.2.4 Argos Therapeutics Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (2016-2021)
  7.2.5 Argos Therapeutics Key News
7.3 AstraZeneca
  7.3.1 AstraZeneca Corporate Summary
  7.3.2 AstraZeneca Business Overview
  7.3.3 AstraZeneca Renal Cell Carcinoma Clinical Trial Pipeline Major Product Offerings
  7.3.4 AstraZeneca Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (2016-2021)
  7.3.5 AstraZeneca Key News
7.4 Aveo Pharmaceuticals
  7.4.1 Aveo Pharmaceuticals Corporate Summary
  7.4.2 Aveo Pharmaceuticals Business Overview
  7.4.3 Aveo Pharmaceuticals Renal Cell Carcinoma Clinical Trial Pipeline Major Product Offerings
  7.4.4 Aveo Pharmaceuticals Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (2016-2021)
  7.4.5 Aveo Pharmaceuticals Key News
7.5 Bayer
  7.5.1 Bayer Corporate Summary
  7.5.2 Bayer Business Overview
  7.5.3 Bayer Renal Cell Carcinoma Clinical Trial Pipeline Major Product Offerings
  7.5.4 Bayer Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (2016-2021)
  7.5.5 Bayer Key News
7.6 Exelixis
  7.6.1 Exelixis Corporate Summary
  7.6.2 Exelixis Business Overview
  7.6.3 Exelixis Renal Cell Carcinoma Clinical Trial Pipeline Major Product Offerings
  7.6.4 Exelixis Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (2016-2021)
  7.6.5 Exelixis Key News
7.7 Incyte
  7.7.1 Incyte Corporate Summary
  7.7.2 Incyte Business Overview
  7.7.3 Incyte Renal Cell Carcinoma Clinical Trial Pipeline Major Product Offerings
  7.4.4 Incyte Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (2016-2021)
  7.7.5 Incyte Key News
7.8 Merck KGaA
  7.8.1 Merck KGaA Corporate Summary
  7.8.2 Merck KGaA Business Overview
  7.8.3 Merck KGaA Renal Cell Carcinoma Clinical Trial Pipeline Major Product Offerings
  7.8.4 Merck KGaA Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (2016-2021)
  7.8.5 Merck KGaA Key News
7.9 Roche
  7.9.1 Roche Corporate Summary
  7.9.2 Roche Business Overview
  7.9.3 Roche Renal Cell Carcinoma Clinical Trial Pipeline Major Product Offerings
  7.9.4 Roche Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (2016-2021)
  7.9.5 Roche Key News
7.10 Novartis
  7.10.1 Novartis Corporate Summary
  7.10.2 Novartis Business Overview
  7.10.3 Novartis Renal Cell Carcinoma Clinical Trial Pipeline Major Product Offerings
  7.10.4 Novartis Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (2016-2021)
  7.10.5 Novartis Key News
7.11 Pfizer
  7.11.1 Pfizer Corporate Summary
  7.11.2 Pfizer Business Overview
  7.11.3 Pfizer Renal Cell Carcinoma Clinical Trial Pipeline Major Product Offerings
  7.11.4 Pfizer Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (2016-2021)
  7.11.5 Pfizer Key News
7.12 Prometheus Labs
  7.12.1 Prometheus Labs Corporate Summary
  7.12.2 Prometheus Labs Business Overview
  7.12.3 Prometheus Labs Renal Cell Carcinoma Clinical Trial Pipeline Major Product Offerings
  7.12.4 Prometheus Labs Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (2016-2021)
  7.12.5 Prometheus Labs Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Renal Cell Carcinoma Clinical Trial Pipeline Market Opportunities & Trends in Global Market
Table 2. Renal Cell Carcinoma Clinical Trial Pipeline Market Drivers in Global Market
Table 3. Renal Cell Carcinoma Clinical Trial Pipeline Market Restraints in Global Market
Table 4. Key Players of Renal Cell Carcinoma Clinical Trial Pipeline in Global Market
Table 5. Top Renal Cell Carcinoma Clinical Trial Pipeline Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue Share by Companies, 2016-2021
Table 8. Global Companies Renal Cell Carcinoma Clinical Trial Pipeline Product Type
Table 9. List of Global Tier 1 Renal Cell Carcinoma Clinical Trial Pipeline Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Renal Cell Carcinoma Clinical Trial Pipeline Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Renal Cell Carcinoma Clinical Trial Pipeline Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2022-2027
Table 30. Amgen Corporate Summary
Table 31. Amgen Renal Cell Carcinoma Clinical Trial Pipeline Product Offerings
Table 32. Amgen Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), (2016-2021)
Table 33. Argos Therapeutics Corporate Summary
Table 34. Argos Therapeutics Renal Cell Carcinoma Clinical Trial Pipeline Product Offerings
Table 35. Argos Therapeutics Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), (2016-2021)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Renal Cell Carcinoma Clinical Trial Pipeline Product Offerings
Table 38. AstraZeneca Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), (2016-2021)
Table 39. Aveo Pharmaceuticals Corporate Summary
Table 40. Aveo Pharmaceuticals Renal Cell Carcinoma Clinical Trial Pipeline Product Offerings
Table 41. Aveo Pharmaceuticals Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), (2016-2021)
Table 42. Bayer Corporate Summary
Table 43. Bayer Renal Cell Carcinoma Clinical Trial Pipeline Product Offerings
Table 44. Bayer Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), (2016-2021)
Table 45. Exelixis Corporate Summary
Table 46. Exelixis Renal Cell Carcinoma Clinical Trial Pipeline Product Offerings
Table 47. Exelixis Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), (2016-2021)
Table 48. Incyte Corporate Summary
Table 49. Incyte Renal Cell Carcinoma Clinical Trial Pipeline Product Offerings
Table 50. Incyte Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), (2016-2021)
Table 51. Merck KGaA Corporate Summary
Table 52. Merck KGaA Renal Cell Carcinoma Clinical Trial Pipeline Product Offerings
Table 53. Merck KGaA Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), (2016-2021)
Table 54. Roche Corporate Summary
Table 55. Roche Renal Cell Carcinoma Clinical Trial Pipeline Product Offerings
Table 56. Roche Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), (2016-2021)
Table 57. Novartis Corporate Summary
Table 58. Novartis Renal Cell Carcinoma Clinical Trial Pipeline Product Offerings
Table 59. Novartis Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), (2016-2021)
Table 60. Pfizer Corporate Summary
Table 61. Pfizer Renal Cell Carcinoma Clinical Trial Pipeline Product Offerings
Table 62. Pfizer Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), (2016-2021)
Table 63. Prometheus Labs Corporate Summary
Table 64. Prometheus Labs Renal Cell Carcinoma Clinical Trial Pipeline Product Offerings
Table 65. Prometheus Labs Renal Cell Carcinoma Clinical Trial Pipeline Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Renal Cell Carcinoma Clinical Trial Pipeline Segment by Type
Figure 2. Renal Cell Carcinoma Clinical Trial Pipeline Segment by Application
Figure 3. Global Renal Cell Carcinoma Clinical Trial Pipeline Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Renal Cell Carcinoma Clinical Trial Pipeline Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Renal Cell Carcinoma Clinical Trial Pipeline Revenue in 2020
Figure 8. By Type - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue Market Share, 2016-2027
Figure 9. By Application - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue Market Share, 2016-2027
Figure 10. By Region - Global Renal Cell Carcinoma Clinical Trial Pipeline Revenue Market Share, 2016-2027
Figure 11. By Country - North America Renal Cell Carcinoma Clinical Trial Pipeline Revenue Market Share, 2016-2027
Figure 12. US Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Renal Cell Carcinoma Clinical Trial Pipeline Revenue Market Share, 2016-2027
Figure 16. Germany Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 17. France Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Renal Cell Carcinoma Clinical Trial Pipeline Revenue Market Share, 2016-2027
Figure 24. China Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 28. India Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Renal Cell Carcinoma Clinical Trial Pipeline Revenue Market Share, 2016-2027
Figure 30. Brazil Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Renal Cell Carcinoma Clinical Trial Pipeline Revenue Market Share, 2016-2027
Figure 33. Turkey Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Renal Cell Carcinoma Clinical Trial Pipeline Revenue, (US$, Mn), 2016-2027
Figure 37. Amgen Renal Cell Carcinoma Clinical Trial Pipeline Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Argos Therapeutics Renal Cell Carcinoma Clinical Trial Pipeline Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. AstraZeneca Renal Cell Carcinoma Clinical Trial Pipeline Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Aveo Pharmaceuticals Renal Cell Carcinoma Clinical Trial Pipeline Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Bayer Renal Cell Carcinoma Clinical Trial Pipeline Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Exelixis Renal Cell Carcinoma Clinical Trial Pipeline Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Incyte Renal Cell Carcinoma Clinical Trial Pipeline Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Merck KGaA Renal Cell Carcinoma Clinical Trial Pipeline Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Roche Renal Cell Carcinoma Clinical Trial Pipeline Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Novartis Renal Cell Carcinoma Clinical Trial Pipeline Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Pfizer Renal Cell Carcinoma Clinical Trial Pipeline Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Prometheus Labs Renal Cell Carcinoma Clinical Trial Pipeline Revenue Year Over Year Growth (US$, Mn) & (2016-2021)